Dr. Bahal of University of Connecticut will receive the award at the opening ceremony of the PharmSci360 meeting.    He joins fellow CPPR faculty, Dr. Tony Zhou of Purdue University, who received the award in 2021.   Dr. Bahal is best known for innovations in nucleic acid-based chemistry and its delivery strategies. 

Kinnari Arte co-chaired the 2023 PGSRM at Purdue University in June where 130 participants from academia and industry exchanged ideas. 

Save the date to meet with faculty, students, and scientists from the pharmaceutical industry at the University of Minnesota.  If you are not a CPPR member and would like to be invited to the meeting, please email us at cppr@uconn.edu. 

Akshay Narula from Dr. Na Li’s laboratory at University of Connecticut was recognized for his outstanding research at the Genentech Graduate Student Symposium. 

The May 2023 issue of @Pharmaceutical Research on Inhalation Therapy is co-edited by Prof. Tony Zhou from @Purdue.  Pharmaceutical Research | Volume 40, issue 5 (springer.com) 

Diane Burgess and coworkers recently licensed a slow-releasing implant designed to reduce side effects associated with medications for pain relief of rheumatoid arthritis and osteoarthritis.  Read more at Pharmacy Researchers License New NSAIDS-Administering Technology – UConn Today

At the May 23 Scientific Conference of the CPPR, Dinesh Choudhary from the lab group of Robin Bogner, won the Emerging Researcher Award named in honor of Steve Nail, co-founder of CPPR.

KinnariArte, from the lab group of QiTonyZhou at Purdue, LingZhu, from the lab group of RobinBogner, and ShipraMalik, recent graduate of the lab group of RamanBahal at UConnPharmacy all gave talks at the recent meeting of ISLFD in Chicago, IL.  Kinnari also won the outstanding poster award at the one-day conference.

Lilly joins Alexion, Astrazeneca, ATS Life Sciences – Scientific Products, Glaxosmithkline, Genentech, Janssen, Roquette, and Sanofi on the CPPR Industrial Advisory Board.  We look forward to Lilly’s participation in our quest to advance pharmaceutical processing. The funds that Lilly has committed to CPPR research are pooled with those of the other member companies.  The funds support rigorous academic research into industrially relevant pharmaceutical processing research at the CPPR academic sites, with mentorship from representatives from CPPR companies.

Fifty-three industrial scientists, faculty, and students gathered to exchange ideas, report on ongoing projects, present proposals, and give final reports on May 23 at University of Connecticut in Storrs, CT. Process advancements in freezing, drying, spraying, mixing, cryopreservation, crystallization, and continuous granulation of small molecular drugs and many biologics were presented.